Drugs / Starbucks® Cold brew
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03878277 | Jul 2019 → Jan 2020 | diabetic kidney disease, type 1 diabetes mellitus | University of Colorado, Denver | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Starbucks Cold brew | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03878277 ↗ |
| Route | Oral | “Participants will be instructed to drink 1 bottle every morning between 6 and 9 am for 6 days prior to the post-intervention visit.” NCT03878277 ↗ |